Literature DB >> 12847241

CD49d overexpression and T cell autoimmunity.

Ru-Ran Mo1, Julie K Eisenbraun, Joanne Sonstein, Ronald A Craig, Jeffrey L Curtis, Lloyd M Stoolman, Jun Chen, Raymond L Yung.   

Abstract

D10.G4.1 (D10) cells, a murine conalbumin-reactive Th2 cell line, made to overexpress the beta(2) integrin LFA-1 by pharmacological manipulation or by transfection become autoreactive and are capable of inducing in vivo autoimmunity. However, whether this is specific to LFA-1 and whether overexpression of other T cell integrin molecules has the same effect are unknown. We examined the functional consequences of T cell CD49d (alpha(4) integrin) overexpression by transfecting murine CD49d cDNA into D10 cells. Similar to the LFA-1-transfected cells, the CD49d-overexpressing T cells are autoreactive and proliferate in response to APCs in an MHC class II-dependent manner in the absence of nominal Ag. Additionally, CD49d overexpression is associated with increased in vitro adhesion to endothelial cells and increased in vivo splenic homing. However, in contrast to LFA-1 overexpression, increased T cell CD49d expression is not associated with autoreactive cytotoxicity or the ability to induce in vivo autoimmunity. In addition to the novel observation that CD49d overexpression is sufficient to induce T cell autoreactivity, our results also support the hypothesis that the ability to induce in vivo autoimmunity is related to T cell cytotoxicity and not to T cell proliferation function in the D10 murine adoptive transfer model of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847241     DOI: 10.4049/jimmunol.171.2.745

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.

Authors:  E Scala; R Paganelli; F Sampogna; D Abeni; L Colonna; O De Pità; P Puddu; G Russo
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

2.  Carbon monoxide down-regulates α4β1 integrin-specific ligand binding and cell adhesion: a possible mechanism for cell mobilization.

Authors:  Alexandre Chigaev; Yelena Smagley; Larry A Sklar
Journal:  BMC Immunol       Date:  2014-10-31       Impact factor: 3.615

Review 3.  Integrin-directed antibody-based immunotherapy: focus on VLA-4.

Authors:  Wilson Savino; Beatriz Chaves; Adriana Cesar Bonomo; Vinicius Cotta-de-Almeida
Journal:  Immunother Adv       Date:  2021-02-09

4.  T Cell Integrin Overexpression as a Model of Murine Autoimmunity.

Authors:  Raymond L. Yung; Donna Ray; Ru Ran Mo; Jun Chen
Journal:  Biol Proced Online       Date:  2003-10-24       Impact factor: 3.244

Review 5.  Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.

Authors:  Elizabeth A Mills; Yang Mao-Draayer
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.